Neglected Tropical Disease Treatment Market Growth Drivers and Outlook 2026–2036

According to FutureWise analysis, the neglected tropical disease treatment market in 2026 is US$3.47 billion, and is expected to reach US$6.91 billion by 2036 at a CAGR of 7.13%. 

Neglected tropical disease treatment market robust growth is driven by intensified global funding commitments from organisations such as the WHO, the Bill & Melinda Gates Foundation, and Gavi, which have collectively channeled billions toward elimination programs targeting diseases such as lymphatic filariasis, leishmaniasis, and schistosomiasis across more than 90 endemic countries. Advances in drug discovery and repurposing strategies — including the development of oral therapeutics and combination therapies — are significantly improving treatment accessibility and patient adherence in resource-limited settings where healthcare infrastructure remains constrained. The growing integration of neglected tropical disease programs within broader universal health coverage initiatives is expanding government procurement and public-private partnership models, creating more sustainable funding pipelines for treatment rollout. Rising political will, reinforced by the WHO's 2030 NTD Roadmap targeting the control or elimination of at least 20 neglected tropical diseases, is further catalyzing coordinated international action and accelerating market development across sub-Saharan Africa, South Asia, and Latin America..

FutureWise Market Research has instantiated a report that provides an intricate analysis of Neglected Tropical Disease Treatment Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=11672&type=requestsample

By Drug Class

• Anti-Parasite
• Antifungal
• Antibiotics
• Others

By Disease Type

• Leishmaniasis
• Schistosomiasis
• Lymphatic Filariasis
• Chagas Disease
• African Trypanosomiasis
• Dengue
• Rabies
• Trachoma
• Buruli Ulcer
• Yaws
• Leprosy
• Soil-Transmitted Helminthiases
• Others

By Distribution Channel

• Direct Sales
• Indirect Sales

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Neglected Tropical Disease Treatment Market:

• F. Hoffmann-La Roche Ltd
• Abbott
• ZeptoMetrix
• Genome Diagnostics Pvt. Ltd
• Omega Diagnostics Group PLC
• Oscar Medicare Pvt Ltd
• Thermo Fisher Scientific, Inc
• Bayer AG
• GlaxoSmithKline plc
• Novartis AG
• Pfizer Inc.
• Eisai Co. Ltd.
• Sanofi
• Astellas Pharma
• Takeda Pharmaceutical Company Limited
• Gilead Sciences
• Ford GoBike

Buy now the latest version of this report:

https://www.futurewiseresearch.com/checkout.aspx?ReportId=11672&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Neglected Tropical Disease Treatment Market By Drug Class, By Disease Type, By Distribution Channel and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/82210-Neglected-Tropical-Disease-Treatment-Market-Growth-Drivers-and-Outlook-2026-2036.html